Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
CA 2364492 C · Owner: Watt, Fujiko · Inventors: Molloy, Peter, Laurence; Watt, Fujiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides regulatory constructs comprising intron 3 of the prostate specific membrane antigen gene (PSMA). An isolated nucleic acid molecule encoding the partial sequence of intron 3 of PSMA a vector and a , recombinant expression cassette are disclosed. The invention also provides a method of directing expression of a coding sequence in a prostate cell a , bladder cell, a breast cell and a vascular endothelial cell using the said constructs. This invention further provides a method of treatment of cancer using the said constructs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 1, 2000 and granted August 19, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.